Oaktree Acquisition Corp. III Life Sciences (OACC) EBIT (2025 - 2026)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of EBIT readings, the most recent being -$456538.0 for Q1 2026.

• Quarterly EBIT fell 2.64% to -$456538.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.2 million through Mar 2026, changed N/A year-over-year, with the annual reading at -$1.2 million for FY2025, 239.87% down from the prior year.
• EBIT hit -$456538.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from -$255496.0 in the prior quarter.
• Across five years, EBIT topped out at -$225579.0 in Q3 2025 and bottomed at -$456538.0 in Q1 2026.

Peer Comparison